Vanguard Group Inc. raised its position in shares of Genpact Limited (NYSE:G – Free Report) by 0.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 16,962,496 shares of the business services provider’s stock after acquiring an additional 61,376 shares during the quarter. Vanguard Group Inc. owned approximately 9.62% of Genpact worth $728,539,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Stifel Financial Corp bought a new stake in shares of Genpact during the third quarter valued at approximately $1,197,000. Blue Trust Inc. lifted its position in Genpact by 8.7% during the fourth quarter. Blue Trust Inc. now owns 5,531 shares of the business services provider’s stock valued at $217,000 after buying an additional 441 shares during the period. Burney Co. boosted its holdings in shares of Genpact by 242.8% during the 4th quarter. Burney Co. now owns 130,798 shares of the business services provider’s stock valued at $5,618,000 after buying an additional 92,641 shares in the last quarter. KBC Group NV purchased a new stake in shares of Genpact in the 4th quarter worth about $298,000. Finally, JPMorgan Chase & Co. increased its stake in shares of Genpact by 192.8% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,129,341 shares of the business services provider’s stock worth $122,701,000 after acquiring an additional 2,060,595 shares in the last quarter. Hedge funds and other institutional investors own 96.03% of the company’s stock.
Insider Transactions at Genpact
In other news, CEO Balkrishan Kalra sold 13,600 shares of the stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total value of $664,904.00. Following the transaction, the chief executive officer now owns 310,246 shares in the company, valued at $15,167,926.94. This represents a 4.20 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Piyush Mehta sold 12,000 shares of the business’s stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $42.83, for a total transaction of $513,960.00. Following the sale, the senior vice president now owns 151,182 shares of the company’s stock, valued at $6,475,125.06. This trade represents a 7.35 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 2.80% of the company’s stock.
Genpact Trading Down 1.5 %
Genpact (NYSE:G – Get Free Report) last announced its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. On average, sell-side analysts predict that Genpact Limited will post 3.21 EPS for the current year.
Genpact Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th were issued a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 1.36%. This is a boost from Genpact’s previous quarterly dividend of $0.15. The ex-dividend date was Tuesday, March 11th. Genpact’s dividend payout ratio is presently 23.94%.
Analyst Upgrades and Downgrades
A number of equities research analysts have weighed in on the stock. TD Cowen upgraded shares of Genpact from a “hold” rating to a “buy” rating and upped their price objective for the stock from $45.00 to $60.00 in a report on Friday, February 7th. Needham & Company LLC upped their price target on Genpact from $55.00 to $65.00 and gave the stock a “buy” rating in a research note on Friday, February 7th. Jefferies Financial Group upgraded Genpact from a “hold” rating to a “buy” rating and lifted their price objective for the company from $44.00 to $55.00 in a research note on Tuesday, January 21st. Finally, Mizuho increased their target price on Genpact from $45.00 to $55.00 and gave the stock a “neutral” rating in a research note on Monday, February 10th. Six analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $48.44.
View Our Latest Stock Report on G
About Genpact
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
See Also
- Five stocks we like better than Genpact
- Upcoming IPO Stock Lockup Period, Explained
- Venezuelan Tariffs Could Power These 3 Diesel-Driven Winners
- Insider Trading – What You Need to Know
- MarketBeat Week in Review – 03/24 – 03/28
- What Is WallStreetBets and What Stocks Are They Targeting?
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.